103
Views
5
CrossRef citations to date
0
Altmetric
Original Articles

A Nitric Oxide Synthase Inhibitor Attenuates Neuropeptide Y—and Clonidine- Induced Feeding in the Neonatal Chick

, , , , &
Pages 257-264 | Received 28 Aug 1999, Accepted 15 Mar 2000, Published online: 11 Nov 2011
 

Abstract

Bungo. T., Choi. Y.-H., Shimojo, M., Masuda. Y., Denbow, D.M. and Furuse, M. 2000. A nitric oxide synthase inhibitor attenuates neuropeptide Y- and clonidine- induced feeding in the neonatal chick. J. Appl. Anim. Res., 17: 257–264.

It is reported that inhibition of nitric oxide (NO) synthase (NOS) decreased food intake in mammalian and avian species. On the other hand, central administration of α2-agonists stimulated, food, intake in both species. Similarly, neuropeptide Y (NPY) has the orcxigenic effect mediated by α2 receptors. The present study was done to determine whether central injection of NG-nitro-L-arginine methyl ester (L-NAME), a NOS inhibitor, in the neonatal chick modulates the increase in food intake induced by NPY- and clonidine (CLON, a specific α2-agonist)-induced food intake. Both NPY (2.5 μg)- and CLON (50 ng)-induced food intake of neonatal chicks was significantly attenuated by co-administration with the higher doses of L-NAME (0, 0.2, 0.4 and 0.8 mg). Our results suggest that NO may interact with orexigenic systems in modulating food intake in the neonatal chick.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.